↓ Skip to main content

Dove Medical Press

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Overview of attention for article published in Vascular Health and Risk Management, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (75th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
95 Mendeley
Title
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
Published in
Vascular Health and Risk Management, March 2014
DOI 10.2147/vhrm.s54714
Pubmed ID
Authors

Bennett Levitan, Zhong Yuan, Alexander GG Turpie, Richard J Friedman, Martin Homering, Jesse A Berlin, Scott D Berkowitz, Rachel B Weinstein, Peter M DiBattiste

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
Slovenia 1 1%
Unknown 93 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 17%
Student > Bachelor 13 14%
Student > Postgraduate 11 12%
Student > Ph. D. Student 10 11%
Other 9 9%
Other 22 23%
Unknown 14 15%
Readers by discipline Count As %
Medicine and Dentistry 65 68%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Agricultural and Biological Sciences 2 2%
Nursing and Health Professions 2 2%
Biochemistry, Genetics and Molecular Biology 1 1%
Other 5 5%
Unknown 17 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2018.
All research outputs
#6,496,106
of 25,374,917 outputs
Outputs from Vascular Health and Risk Management
#209
of 804 outputs
Outputs of similar age
#57,417
of 236,354 outputs
Outputs of similar age from Vascular Health and Risk Management
#7
of 16 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 804 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.3. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,354 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.